αCD40University of Virginiacancerbreast cancerBCNIH DP5OD031846
…D4+ T cells following rechallenge (figure 2O).Conclusions T-FUS+αCD40 represents a novel paradigm for immunotherapy of BC-capable of …
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: αCD40 ×
αCD40
This drug is selected. Its supporting articles are shown below.